Cambrian BioPharma raises $123.8 million in Rule 506(c) equity offering
Cambrian BioPharma Inc, a Delaware biotechnology corporation, conducted a Rule 506(c) general solicitation equity offering with a total target of $129,751,064.
$130Moffering$124M